Business · 15/11/2018
FDA Proposes Rule to Exempt Minimal Risk Clinical Investigations from Informed Consent Requirements
The FDA is proposing to amend its regulations to allow for exceptions to informed consent requirements for minimal risk clinical investigations, which would be subject to safeguards to protect human subjects' rights and safety.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →